GlassScriptPhysician profile
Carl M Christman
NPI 1538116629
$4,422.84
in general payments reported to CMS, 2019-2025
24 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $336 · 2021: $803 · 2022: $733 · 2023: $786 · 2024: $799 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.46 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,103.27 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Astellas Pharma US INC | $514.83 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $479.93 | 2019-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Pfizer INC. | $454.68 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $291.52 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $269.20 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $180.71 | 2023-2025 | Myfembree, Gemtesa |
| Intuitive Surgical, INC. | $179.26 | 2020-2022 | |
| Medtronic, INC. | $135.93 | 2022-2023 | Truclear |
| Allergan, INC. | $134.32 | 2019-2020 | |
| Coopersurgical, INC. | $131.18 | 2020-2021 | |
| Myovant Sciences INC. | $126.36 | 2021-2022 | |
| Agile Therapeutics, INC. | $73.01 | 2021-2024 | Twirla |
| Conmed Corporation | $62.50 | 2020 | |
| Evofem Biosciences, INC. | $59.92 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $54.10 | 2019-2020 | |
| Biogen, INC. | $36.10 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $33.44 | 2023-2024 | Slynd |
| Daiichi Sankyo INC. | $27.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $20.39 | 2024 | Gardasil, Gardasil 9 |
| Exact Sciences Corporation | $15.63 | 2025 | The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $14.38 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.70 | 2021 | |
| Duchesnay USA Incorporated | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Christman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.